David N. Krag

16.7k total citations · 4 hit papers
166 papers, 12.5k citations indexed

About

David N. Krag is a scholar working on Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David N. Krag has authored 166 papers receiving a total of 12.5k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Oncology, 68 papers in Cancer Research and 49 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David N. Krag's work include Breast Cancer Treatment Studies (62 papers), Monoclonal and Polyclonal Antibodies Research (38 papers) and Breast Lesions and Carcinomas (36 papers). David N. Krag is often cited by papers focused on Breast Cancer Treatment Studies (62 papers), Monoclonal and Polyclonal Antibodies Research (38 papers) and Breast Lesions and Carcinomas (36 papers). David N. Krag collaborates with scholars based in United States, Australia and Iran. David N. Krag's co-authors include Donald L. Weaver, James C. Alex, Seth P. Harlow, Jonathan T. Fairbank, Takamaru Ashikaga, Thomas B. Julian, Norman Wolmark, Stewart Anderson, Joseph P. Costantino and Eleftherios P. Mamounas and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

David N. Krag

162 papers receiving 12.1k citations

Hit Papers

The Sentinel Node in Breast Cancer — A Multicenter Valida... 1993 2026 2004 2015 1998 1993 2010 2007 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Sentinel Node in Breast Cancer — A Multicenter Validation Study
    1998 1.6k citations David N. Krag, Donald L. Weaver et al. profile →
  2. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe
    1993 1.3k citations David N. Krag, Donald L. Weaver et al. profile →
  3. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
    2010 1.3k citations David N. Krag, Stewart Anderson et al. profile →
  4. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial
    2007 773 citations David N. Krag, Stewart Anderson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David N. Krag United States 50 7.0k 5.5k 5.2k 4.6k 1.4k 166 12.5k
Melvin Deutsch United States 43 9.3k 1.3× 5.5k 1.0× 5.8k 1.1× 5.7k 1.3× 1.7k 1.2× 161 15.6k
Viviana Galimberti Italy 67 12.6k 1.8× 8.6k 1.5× 6.0k 1.2× 6.7k 1.5× 1.3k 1.0× 244 16.9k
Paolo Veronesi Italy 74 12.9k 1.8× 8.3k 1.5× 7.3k 1.4× 7.4k 1.6× 1.9k 1.4× 457 20.1k
Patrick I. Borgen United States 65 7.5k 1.1× 5.8k 1.0× 4.3k 0.8× 3.7k 0.8× 843 0.6× 179 13.5k
Wei Yang United States 54 4.9k 0.7× 3.9k 0.7× 3.5k 0.7× 2.0k 0.4× 2.9k 2.1× 308 10.2k
Lawrence J. Solin United States 69 9.7k 1.4× 6.2k 1.1× 6.3k 1.2× 4.7k 1.0× 4.4k 3.2× 236 17.9k
Isabelle Bedrosian United States 54 5.8k 0.8× 3.5k 0.6× 4.0k 0.8× 2.7k 0.6× 826 0.6× 238 9.3k
Jong‐Hyeon Jeong United States 37 7.5k 1.1× 3.5k 0.6× 5.0k 1.0× 3.0k 0.7× 1.6k 1.2× 138 11.7k
Franco Rilke Italy 53 5.1k 0.7× 4.4k 0.8× 5.5k 1.1× 2.5k 0.5× 1.1k 0.8× 198 12.3k
Giovanni Paganelli Italy 70 7.2k 1.0× 6.1k 1.1× 7.1k 1.4× 4.7k 1.0× 5.8k 4.2× 363 18.9k

Countries citing papers authored by David N. Krag

Since Specialization
Citations

This map shows the geographic impact of David N. Krag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David N. Krag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David N. Krag more than expected).

Fields of papers citing papers by David N. Krag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David N. Krag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David N. Krag. The network helps show where David N. Krag may publish in the future.

Co-authorship network of co-authors of David N. Krag

This figure shows the co-authorship network connecting the top 25 collaborators of David N. Krag. A scholar is included among the top collaborators of David N. Krag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David N. Krag. David N. Krag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krag, David N., et al.. (2025). Speed and accuracy of online searches by legislators and medical students using RefBin’s opioid use disorder database. The American Journal of Drug and Alcohol Abuse. 51(2). 173–179.
2.
Ashikaga, Takamaru, et al.. (2022). Pilot trial comparing COVID-19 publication database to conventional online search methods. BMJ Health & Care Informatics. 29(1). e100616–e100616. 1 indexed citations
3.
4.
5.
Sun, Yujing, Girja S. Shukla, Stephanie C. Pero, et al.. (2012). Single Tumor Imaging with Multiple Antibodies Targeting Different Antigens. BioTechniques. 52(4). 216–216. 2 indexed citations
6.
Kopec, Jacek A., Linda H. Colangelo, Stephanie R. Land, et al.. (2012). Relationship Between Arm Morbidity and Patient-Reported Outcomes Following Surgery in Women with Node-Negative Breast Cancer: NSABP Protocol B-32. PubMed. 11(1). 22–30. 15 indexed citations
7.
Pero, Stephanie C., Menachem J. Gunzburg, Daniel Clayton, et al.. (2011). Structural Basis of Binding by Cyclic Nonphosphorylated Peptide Antagonists of Grb7 Implicated in Breast Cancer Progression. Journal of Molecular Biology. 412(3). 397–411. 18 indexed citations
8.
Shukla, Girja S. & David N. Krag. (2010). Novel β-lactamase-random peptide fusion libraries for phage display selection of cancer cell-targeting agents suitable for enzyme prodrug therapy. Journal of drug targeting. 18(2). 115–124. 8 indexed citations
9.
Gür, Deniz, Suling Liu, Anurag Shukla, et al.. (2009). Identification of single chain antibodies to breast cancer stem cells using phage display. Biotechnology Progress. 25(6). 1780–1787. 11 indexed citations
10.
Weaver, Donald L., David N. Krag, Edward Manna, et al.. (2006). Detection of occult sentinel lymph node micrometastases by immunohistochemistry in breast cancer. Cancer. 107(4). 661–667. 29 indexed citations
11.
Shukla, Girja S. & David N. Krag. (2005). Phage display selection for cell-specific ligands: Development of a screening procedure suitable for small tumor specimens. Journal of drug targeting. 13(1). 7–18. 39 indexed citations
12.
Shukla, Girja S. & David N. Krag. (2005). A Sensitive and Rapid Chemiluminescence ELISA for Filamentous Bacteriophages. Journal of Immunoassay and Immunochemistry. 26(2). 89–95. 12 indexed citations
13.
Krag, David N. & Richard M. Single. (2003). Breast Cancer Survival According to Number of Nodes Removed. Annals of Surgical Oncology. 10(10). 1152–1159. 75 indexed citations
14.
Harlow, Seth P., David N. Krag, Takashi Ashikaga, et al.. (2001). Gamma probe guided biopsy of the sentinel node in malignant melanoma: a multicentre study. Melanoma Research. 11(1). 45–55. 63 indexed citations
15.
Weaver, Donald L., David N. Krag, Takamaru Ashikaga, Seth P. Harlow, & Maureen O’Connell. (2000). Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma. Cancer. 88(5). 1099–1107. 4 indexed citations
16.
Weaver, Donald L., David N. Krag, Takamaru Ashikaga, Seth P. Harlow, & Maureen O’Connell. (2000). Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma. Cancer. 88(5). 1099–1107. 167 indexed citations
17.
Rubio, Isabel T., Soheila Korourian, Christopher Cowan, et al.. (1998). Sentinel lymph node biopsy for staging breast cancer. The American Journal of Surgery. 176(6). 532–537. 83 indexed citations
18.
Lung, Feng‐Di T., Lakshmi Sastry, James C. Bigelow, et al.. (1997). Nonphosphorylated Peptide Ligands for the Grb2 Src Homology 2 Domain. Journal of Biological Chemistry. 272(46). 29046–29052. 90 indexed citations
19.
Théon, Alain P., John R. Pascoe, Gary P. Carlson, & David N. Krag. (1993). Intratumoral chemotherapy with cisplatin in oily emulsion in horses. Journal of the American Veterinary Medical Association. 202(2). 261–267. 115 indexed citations
20.
Surwit, Earl A., Joel M. Childers, David N. Krag, et al.. (1993). Clinical Assessment of 111In-CYT-103 Immunoscintigraphy in Ovarian Cancer. Gynecologic Oncology. 48(3). 285–292. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melvin Deutsch Breakdown of academic impact, for papers by Viviana Galimberti Breakdown of academic impact, for papers by Paolo Veronesi Breakdown of academic impact, for papers by Patrick I. Borgen Breakdown of academic impact, for papers by Wei Yang Breakdown of academic impact, for papers by Lawrence J. Solin Breakdown of academic impact, for papers by Isabelle Bedrosian Breakdown of academic impact, for papers by Jong‐Hyeon Jeong Breakdown of academic impact, for papers by Franco Rilke Breakdown of academic impact, for papers by Giovanni Paganelli
Rankless by CCL
2026